Delivery Order SPE2DB20D3103-SPE2DB25FP8B7
- Not listed
- The Defense Logistics Agency awarded a $2,289.37 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL vials, with an ultimate completion date of July 30, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials, with a ceiling value of $1,179.45 and a firm fixed price structure. This delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL quantities, with a ceiling value of $4,992.01. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The contract utilizes no set-aside designation, indicating it was awarded through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,218.01 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL units. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, was awarded competitively with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.16 to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 mL (5 mL vials) on July 30, 2025, with completion scheduled for July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product, with a ceiling value of $40,708.85. The delivery order has a firm fixed price and is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Betamethasone SP-AC 30 mg/5 ml 5 ml medication. The contract has a firm fixed price of $1,174.93 and a period of performance through April 30, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,010.79, is for the supply of BETAMETHASONE SP-AC 30 MG/5 ML 5ML, a pharmaceutical product. The contract is a firm fixed-price arrangement with a period of performance through November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of BETAMETHASONE SP-AC 30 MG/5 ML 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $3,530.66 and a completion date of June 9, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract is not a set-aside and was awarded on June 6, 2025. Additionally, Amerisourcebergen Drug...
- This federal contract award is for the delivery of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,502.96 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8B7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials, with a ceiling value of $3,226.34 and a firm fixed price structure. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The ultimate completion date for this delivery order is August 11, 2025, with performance being fulfilled at the vendor's Conshohocken, Pennsylvania facility. This contract type and pricing structure are consistent with AmerisourceBergen's role as a primary pharmaceutical distributor for federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical and healthcare solutions distributor serving military and veteran healthcare systems. The company holds a substantial prime indefinite delivery vehicle with the DLA that enables it to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized medical commodities across multiple therapeutic domains to support defense health programs globally. This delivery order for Betamethasone, a corticosteroid medication commonly used in military medical applications, exemplifies the routine pharmaceutical supply operations executed under this master contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/8/25 |